908 Devices sets IPO pricing terms
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has priced its 6.25 million shares at a price range between $15 and $17 per share.
Boston-based 908 Devices, a provider of analytical devices for chemical and biomolecular analysis, has priced its 6.25 million shares at a price range between $15 and $17 per share.
Copyright PEI Media
Not for publication, email or dissemination